Some chemotherapeutic agents can elicit apoptotic cancer cell death, thereby activating an anticancer immune response that influences therapeutic outcome. We previously reported that anthracyclins are particularly efficient in inducing immunogenic cell death, correlating with the pre-apoptotic exposure of calreticulin (CRT) on the plasma membrane surface of anthracyclintreated tumor cells. Here, we investigated the role of cellular Ca 2 þ homeostasis on CRT exposure. A neuroblastoma cell line (SH-SY5Y) failed to expose CRT in response to anthracyclin treatment. This defect in CRT exposure could be overcome by the overexpression of Reticulon-1C, a manipulation that led to a decrease in the Ca 2 þ concentration within the endoplasmic reticulum lumen. The combination of Reticulon-1C expression and anthracyclin treatment yielded more pronounced endoplasmic reticulum Ca 2 þ depletion than either of the two manipulations alone. Chelation of intracellular (and endoplasmic reticulum) Ca 2 þ , targeted expression of the ligand-binding domain of the IP 3 receptor and inhibition of the sarco-endoplasmic reticulum Ca 2 þ -ATPase pump reduced endoplasmic reticulum Ca 2 þ load and promoted pre-apoptotic CRT exposure on the cell surface, in SH-SY5Y and HeLa cells. These results provide evidence that endoplasmic reticulum Ca 2 þ levels control the exposure of CRT.
In contrast to prior belief, apoptotic cell death can be immunogenic and hence elicits an active immune response against dying tumor cells. 1 This is therapeutically relevant because immune defects that compromise the response against apoptotic cells reduce the efficacy of anticancer chemotherapy, both in suitable animal models and in patients. 2 We found that anthracyclins and g-irradiation are particularly efficient in inducing immunogenic cell death, at least in mouse models. [3] [4] [5] The immunogenicity of cellular demise correlates with the exposure of calreticulin (CRT) on the plasma membrane (PM) surface of stressed tumor cells, a phenomenon that manifests before the cells acquire signs of apoptosis such as phosphatidylserine exposure. Inhibition of CRT exposure curtails the capacity of anthracyclin-treated or irradiated tumor cells to vaccinate against cancer and reduces the therapeutic efficacy of anthracyclins on tumors established in immunocompetent hosts. [3] [4] [5] Provision of recombinant CRT or drug-mediated enforcement of CRT exposure rendered per se nonimmunogenic chemotherapies (for instance with etoposide and mitomycin C) immunogenic and boosted their therapeutic efficacy. 5 These results suggest that CRT exposure is both necessary and sufficient to render conventional chemotherapies immunogenic.
CRT is an abundant Ca 2 þ -binding chaperone that is mostly present in the endoplasmic reticulum (ER) lumen, although it can also be found in other subcellular localizations. 6, 7 When present on the surface of damaged cells, it can serve as an 'eat-me' signal and hence facilitate the recognition and later engulfment of the dying cells by macrophages 8 or by dendritic cells. 5 It is thought that this function determines the immunostimulatory effect of CRT, because presentation of tumor antigens by dendritic cells is indeed required for the immunogenic effect of anthracyclin-treated cancer cells. 1, 5, 9 Alternatively or in addition, CRT may bind antigenic peptides from the tumor and facilitate their efficient presentation to T cells. 10 The exposure of CRT on the cell surface induced by anthracyclins has been found to involve the translocation of pre-synthetized CRT, through an active process that relies on the activity of the actin cytoskeleton. 2 It occurs within minutes after addition of the anthracyclin and does not involve a general mixing of the ER membrane with the PM, as indicated by the fact that the ER transmembrane protein calcineurin (a close CRT homolog) is not found on the cell surface. 5 This is at difference with the reported mixing of intracellular membranes from the Golgi apparatus with the PM, which occurs at late-stage apoptosis concomitant with membrane blebbing. 11, 12 Importantly, it has been found that cytoplasts (that is cells lacking a nucleus) were still able to expose CRT on the cell surface when they were treated with anthracyclins. 5 This result indicates that anthracyclins induce CRT exposure through a non-nuclear, cytoplasmic effect. Thus, the anthracyclin-stimulated CRT exposure is not mediated by a classical DNA damage response (which would involve the nucleus). Anthracyclins have been reported to exert a direct toxic effect on the PM, 13 to stimulate ceramide synthesis, 14 to induce the generation of reactive oxygen species, 15, 16 and to affect intracellular Ca 2 þ homeostasis, mainly by reducing ER Ca 2 þ concentrations, 17, 18 perhaps through a direct effect on ER proteins such as calsequestrin. 19 Based on the aforementioned information, we decided to investigate the impact of ER Ca 2 þ homeostasis on the regulation of CRT exposure on the surface of anthracyclintreated tumor cells. To this aim, we characterized a neuroblastoma cell line, demonstrating that it fails to expose CRT on the surface upon treatment with anthracyclins, yet recovers this capacity after expression of a tetracyclineinducible reticulon-1C (RTN-1C) transgene, correlating with a reduced ER Ca 2 þ level. In addition, we used an extensive repertoire of pharmacological and genetic manipulations of the ER Ca 2 þ influx and efflux to document that a reduction of ER Ca 2 þ concentrations can favor the translocation of CRT to the cell surface.
Results and Discussion
Establishment and characterization of human neuroblastoma cells expressing inducible RTN-1C. Reticulons (RTNs) are evolutionary conserved proteins that are differentially expressed in different cell types. [20] [21] [22] RTNs localize primarily to the ER membrane and possess unique N-terminal parts and a common 200-amino-acid C-terminal domain containing two long hydrophobic sequences that were suggested to form Ca 2 þ -permeable pores in the ER membrane. [23] [24] [25] RTN-1C represents the smallest variant of the reticulon 1 gene 26 and it is specifically expressed by neurons and cells of neuroendocrine tissue. 27 In our study, we used the previously developed tetracycline-inducible SH-SY5Y  RTN-1C human neuroblastoma model  23 consisting of a  SH-SY5Y cell line stably expressing tetracycline-inducible  RTN-1C (SH-SY5Y RTN-1C ) and a control cell line expressing the regulator vector alone (SH-SY5Y Tet12 ) (Figure 1a ). After addition of doxycycline, a tetracycline derivative, SH-SY5Y RTN-1C cells overexpress RTN-1C within hours, reaching a peak around 6 h that remains constant for several days (Figure 1b) . While most of the RTN-1C is present on intracellular membranes ('Endo-RTN-1C') ( Figure 1c) , some of it can also be detected on the PM surface ('Ecto-RTN-1C') by immunofluorescence staining of nonpermeabilized cells, either by digital imaging (Figure 1d ) or cytofluorometric detection (Figure 1e ). We have previously observed that RTN-1C-overexpressing cells (that is SH-SY5Y RTN-1C treated with doxycycline) are relatively resistant against DNAdamaging agents such as etoposide or cisplatin, as compared to controls (SH-SY5Y
Tet12 or SH-SY5Y RTN-1C cells cultured in tetracycline-free conditions). 23 In contrast, we found that the overexpression of RTN-1C had no effect on the propensity of cells to expose phosphatidylserine and to lose viability (Figure 2a Tet12 , no increase in the expression of ecto-CRT could be detected. Thus, the level of ecto-CRT, as detectable by immunofluorescence staining and subsequent cytofluorometric analysis, did not increase in MITO-treated SH-SY5Y
Tet12 cells (Figure 3a , top panels). In marked contrast, we found that SH-SY5Y neuroblastoma cells cultured in the presence of MITO did manifest an increase in the ecto-CRT level, as detectable by flow cytometry as soon as 30 or 120 min after addition of MITO (Figure 3a , bottom panels). It should be noted that neither SH-SY5Y
Tet12 nor SH-SY5Y RTN-1C cells did manifest any signs of apoptosis at these time points (Figure 2a and b) , meaning that the MITO-induced ecto-CRT exposure is an early event. MITO-triggered ecto-CRT exposure is a preapoptotic feature in the sense that it is found on cells that still lack phosphatidylserine exposure. Later, after 24 h of stimulation, MITO induced bona fide apoptosis, exactly as in mouse colon cancer and fibrosarcoma cells, 1 as indicated by chromatin condensation (not shown) and caspase activation (Figure 2c ). MITO did not induce an increase in total CRT levels, as determined by immunoblot analysis (Figure 3b ), suggesting that ecto-CRT exposure is due to the redistribution rather than de novo synthesis of CRT. The increase in ecto-CRT on the surface of doxycyclinepretreated and MITO-treated SH-SY5Y RTN-1C cells could also be detected by in situ immunofluorescence staining, revealing a patchy distribution of ecto-CRT, usually only in one single area of the PM (Figure 3c ). While there was some background staining in control cells, we consistently found an increase in ecto-CRT when the overexpression of RTN-1C was combined with MITO treatment. Although ecto-CRT colocalized with ecto-RTN-1C in the same area of the cell surface (Figure 3d) , we failed to co-immunoprecipitate CRT and RTN-1C either before or after MITO treatment (not shown). Accordingly, the subcellular localization of endo-CRT and endo-RTN-1C only partially overlapped, as determined by confocal imaging of permeabilized cells (Supplementary Figure 1) . As an internal control, brefeldin A (BFA) fully blocked the ecto-CRT exposure induced by MITO in RTN-1C-overexpressing cells (Figure 4a ), causing a perinuclear accumulation of endo-CRT and endo-RTN-1C ( Figure 4b ). This indicates that the anthracyclin-induced translocation of CRT from the ER to the cell surface is not due to passive leakage of the protein from the lumen of the ER, suggesting that it is plausibly an active process.
Altogether, these results indicate that RTN-1C can facilitate the active translocation of pre-formed CRT from the cytoplasm (endo-CRT) to the cell surface (ecto-CRT).
RTN-1C and MITO reduce ER luminal [Ca
2 þ ] in a concerted manner. In order to determine the effect of RTN-1C overexpression on ER Ca 2 þ homeostasis, SH-SY5Y RTN-1C cells were infected with an adenoviral construct encoding ER-targeted low-affinity aequorin probe (ad-er-AEQ), and RTN-1C induction was achieved by the addition of doxycycline as detailed above (see Figure 1b) .
The steady-state concentration of Ca 2 þ in the ER lumen ([Ca 2 þ ] ER ) varies between 200 and 800 mM, depending on the cell type and the state of the cell, and is determined by the balance between Ca 2 þ accumulation into and Ca 2 þ release from the organelle. In the last decade, several methods have been developed for dynamic assessment of [Ca 2 þ ] ER in living cells. 28 The aequorin-based measurement, applied in our study, is based on a protocol which includes (i) pre-incubation of cells with the aequorin cofactor coelenterazine n, following complete Ca 2 þ depletion of the ER in Ca 2 þ -free medium; (ii) refilling of the ER by addition of 1 mM CaCl 2 33, 34 ; and (iii) the Ca 2 þ leak observed after inhibition of SERCA-mediated Ca 2 þ uptake by 2,5-di(t-butyl)-1,4-benzohydroquinone (tBHQ) 29 ( Figure 5a ). As shown on Figure 5a Tet12 and SH-SY5Y RTN-1C cells were treated with 1 mM MITO for the indicated times and equal amounts of total proteins were subjected to immunoblot detection of pro-caspase 9 (46 kDa) and cleaved caspase-3 (17, 19 kDa . Based on these data, we concluded that Ca 2 þ is a major regulator of CRT translocation. In particular, it appears that the reduction of Ca 2 þ refilling into the ER from the extracellular space serves as a trigger for CRT translocation. It is important to note that none of these manipulations induced apoptosis within the time frame that was analyzed (2 h for MITO, BAPTA-AM, 24 h post-transfection for ER-IP 3 R-LBD 224-605 ), underscoring that CRT exposure is not directly linked to cell death.
The refilling of the ER after Ca 2 þ depletion was recently explained in mechanistic terms by the interaction of Ca 2 þ sensors residing in the ER membrane and store-operated Ca 2 þ channels of the PM (e.g. the Orai family of Ca 2 þ channels). 37,38 ER Ca 2 þ depletion triggers activation of Ca 2 þ influx through the PM, which is immediately taken up by the ER through the SERCA pumps. 32 To determine whether reduced ER refilling of RTN-1C-overexpressing cells reflects inhibition of Ca 2 þ influx through the PM, or inhibition of active transport into the ER lumen by the SERCA pumps, we applied two different approaches.
First, we measured the kinetics of Ca 2 þ uptake into the ER in cells in which the PM was permeabilized by a low dose of digitonin. Increasing the concentration of ATP (from 100 to 
SH-SY5Y
RTN-1C cells with (RTN-1C overexpressing) or without (controls) doxycycline treatment were first perfused with Ca 2 þ -free Krebs Ringer-modified Buffer (KRB) containing 100 mM EGTA and then treated for 5 min with 50 mM tBHQ to deplete ER Ca 2 þ content. At last, Ca 2 þ influx was induced by the addition of 1 mM CaCl 2 to the KRB buffer while removing EGTA (Figure 8b, left panel) . Importantly, RTN-1C overexpression significantly reduced the Ca 2 þ influx rate (Figure 8b, right panel) , unraveling the molecular target by which the protein exerts its effect on Ca 2 þ refilling of the ER. In conclusion, we deciphered the complex mechanism by which RTN-1C modifies ER and cellular Ca 2 þ homeostasis. This mechanism includes actions both on the ER and the PM, in agreement with the double localization of the protein. Indeed, RTN-1C appears to increase Ca 2 þ leak from the ER lumen to the cytosol, accounting for elevated basal [Ca 2 þ ] c as they were observed in doxycycline-treated SH-SY5Y cells. 23 In addition, RTN-1C also inhibits capacitative Ca 2 þ influx at the PM level, further reducing the steady-state [Ca 2 þ ] in the ER. Similarly, the effect of RTN-1C on CRT cell surface exposure cannot be accounted for by an effect on a single target. Thus, even though the reduction of ER Ca 2 þ refilling by RTN-1C was mediated by the inhibition of PM Ca 2 þ channels, inhibition of the SERCA pump by thapsigargin was also able to induce CRT exposure, and this effect was more evident in SH-SY5Y RTN-1C cells following RTN-1C induction (Figure 8c ). This suggests that any manipulation leading to [Ca 2 þ ] ER depletion may stimulate CRT exposure, irrespective of the exact mechanism by which this depletion is achieved. Further experiments are needed to clarify the exact role of the individual components of ER Ca 2 þ homeostasis in generating the signal for triggering CRT exposure onto the cellular surface. Whether cell surface CRT itself modifies Ca 2 þ fluxes cannot be excluded, yet appears improbable because this protein has thus far been viewed as a mere Ca 2 þ buffer. Indeed, induction of CRT exposure with inhibitors of protein phosphatase 1 (PP1) failed to cause significant changes in 
Concluding Remarks
Based on the data summarized in this work, we assume that ER Ca 2 þ homeostasis plays a major role in the regulation of CRT exposure as it is induced by anthracyclins. Our data corroborate that anthracyclins can reduce the ER Ca 2 þ concentration. [17] [18] [19] Although statistically significant and consistent (in more than 15 independent experiments), this effect is far from spectacular, at least in SH-SY5Y neuroblastoma cells. Upon RTN-1C overexpression (which reduces ER Ca 2 þ influx and hence further lowers the [Ca 2 þ ] ER ) or after treatment with the Ca 2 þ chelator BAPTA-AM (which also reduces ER Ca 2 þ influx), however, SH-SY5Y cells acquired the capacity to expose CRT in response to anthracyclins. These results suggest that threshold effects operating at the level of [Ca 2 þ ] ER may determine the propensity of different cell types to translocate CRT to the cell surface. As a further indication that [Ca 2 þ ] ER controls CRT exposure, we observed that two further specific manipulations designed to lower [Ca 2 þ ] ER could stimulate the appearance of CRT on the cell surface: inhibition of SERCA pumps with thapsigargin and transfection with ER-IP 3 R-LBD .
Although the before mentioned results clearly demonstrate that [Ca 2 þ ] ER controls CRT exposure, several problems We have recently reported that CRT exposure could be observed in a fraction of circulating leukemia cells from patients treated by intravenous injection with anthracyclins. 39 However, CRT exposure could not be found in all leukemias, pointing to a hitherto unsuspected heterogeneity in the mechanisms of CRT exposure. The mechanisms accounting for this deficient CRT exposure remain largely elusive, although they may be related to altered ER Ca 2 þ homeostasis. It is tempting to speculate that tumors that fail to expose CRT would be refractory to the immunological component of chemotherapy and hence would demonstrate a poorer prognosis than tumors that conserve an intact CRT translocation response. This possibility is currently under intense investigation in our laboratory. Cells, transfection, treatments. The stably transfected clones for RTN-1C sense were obtained as previously described. 23 The SH-SY5Y human neuroblastoma cell line and the derived clones were grown in 1 : 1 mixture of Dulbecco's modified Eagle's medium (DMEM) and Ham's F12 with Glutamax (GIBCO, Invitrogen) supplemented with 10% tetracycline-free heat-inactivated fetal bovine serum (FBS, Clontech) in a humidified atmosphere of 5% CO 2 in air under selective conditions by adding blasticidin and zeocin periodically. HeLa cells were maintained in DMEM supplemented with 10% heat-inactivated FBS, 10 mM Hepes, 100 U/ml penicillin, and 100 mg/ml streptomycin. For transfection of HeLa cells, 1 Â 10 5 cells/well were seeded into 12-well plates and transfected 24 h later with each expression vector plasmid by using lipofectaminet 2000 according to the manufacturer's instructions. All experiments in SH-SY5Y were performed on cells after 12 h of induction by doxycycline (2 mg/ml).
Assessment of apoptosis. Redistribution of PM phosphatidylserine is a marker of apoptosis and was assessed by annexin fluorescein isothiocyanate (MACS, Miltenyi Biotech) according to the manufacturer's protocol. Briefly, 2 Â 10 5 cells per sample were collected, washed in phosphate-buffered saline (PBS), pelleted, and resuspended in incubation buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl 2 ) containing 1% annexin V. Samples were kept in the dark and incubated for 15 min prior to addition of another 400 ml of incubation buffer and subsequent analysis on a fluorescence-activated cell sorter Calibur flow cytometer (Becton Dickinson) using Cell Quest software. Immunofluorescence. For surface staining: cells were cultured on 13 mmround glass coverslips as described above. After treatment, cells were placed on ice, washed twice with PBS and fixed in 0.25% PFA in PBS for 5 min. Cells were then washed twice in PBS and primary antibody, diluted in cold blocking buffer, was added for 30 min. After three washes in cold PBS, cells were incubated for 30 min with the appropriate secondary antibody diluted 1:500 in cold blocking buffer. Cells were washed with PBS and mounted on slides with the mounting medium including DAPI from Vectashield. For intracellular staining: cells were washed with PBS, fixed with 4% PFA for 15 min, permeabilized with 0.1% Triton X-100 for 10 min, rinsed three times with PBS, and nonspecific binding sites were blocked with 10% FBS in PBS for 30 min. Primary antibody was added for 1 h. Subsequently, cells were washed three times with PBS and incubated for 30 min in Alexa Fluor FITC or TRITC-conjugated secondary antibodies (1:1000, Molecular Probes). Specimens were imaged by a brightfield microscope coupled to a cooled CCD camera or a Zeiss LSM 510 confocal system.
Western blot analyses. Cells were harvested and homogenized in RIPA lysis buffer (10 mM Tris, pH 7.2, 150 mM NaCl, 1% deoxycholate, 1% Triton, 0.1% SDS, 5 mM EDTA) containing complete protease inhibitor cocktail (Roche Diagnostics, Meylan, France). After 1 h on ice, samples were sonicated and protein quantification was carried out using a Bio-Rad protein assay. Equal amounts of soluble proteins (15-25 mg) were denaturated by boiling and resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. After blocking in 5% non-fat dry milk in PBS for 1 h and probing with a specific primary antibody and a horseradish peroxidase-conjugated secondary antibody, the protein bands were detected by chemiluminescence (Supersignal, Pierce) and X-ray film exposure (Kodak). Protein loading was normalized by using anti-tubulin or anti-actin antibodies.
